001     298576
005     20250404155750.0
024 7 _ |a 10.1158/1055-9965.EPI-24-1534
|2 doi
024 7 _ |a pmid:39898780
|2 pmid
024 7 _ |a 1055-9965
|2 ISSN
024 7 _ |a 1538-7755
|2 ISSN
037 _ _ |a DKFZ-2025-00293
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Chalitsios, Christos V
|0 0000-0002-0836-9385
|b 0
245 _ _ |a Waist circumference, a body shape index, and molecular subtypes of colorectal cancer: A pooled analysis of four cohort studies.
260 _ _ |a Philadelphia, Pa.
|c 2025
|b AACR
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1743775030_29881
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a 2025 Apr 3;34(4):568-577
520 _ _ |a Background Waist circumference (WC) and its allometric counterpart, 'a body shape index' (ABSI), are risk factors for colorectal cancer (CRC); however, it is uncertain whether associations with these body measurements are limited to specific molecular subtypes of the disease. Methods Data from 2,772 CRC cases and 3,521 controls were pooled from four cohort studies within the Genetics and Epidemiology of Colorectal Cancer Consortium. Four molecular markers (BRAF mutation, KRAS mutation, CpG island methylator phenotype, and microsatellite instability) were analysed individually and in combination (Jass-types). Multivariable logistic and multinomial logistic models were used to assess the associations of WC and ABSI with overall CRC risk and in case-only analyses evaluating heterogeneity by molecular subtype, respectively. Results Higher WC (ORper 5cm=1.06, 95%CI:1.04-1.09) and ABSI (ORper 1-SD=1.07, 95%CI:1.00-1.14) were associated with elevated CRC risk. There was no evidence of heterogeneity between the molecular subtypes. No difference was observed regarding the influence of WC and ABSI on the four major molecular markers in proximal colon, distal colon, and rectal cancer, as well as in early and later onset CRC. Associations did not differ in the Jass-type analysis. Conclusions Higher WC and ABSI were associated with elevated CRC risk; however, they do not differentially influence all four major molecular mutations involved in colorectal carcinogenesis but underscore the importance of maintaining a healthy body weight in CRC prevention. Impact The proposed results have potential utility in colorectal cancer prevention.
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
700 1 _ |a Markozannes, Georgios
|0 0000-0001-8481-579X
|b 1
700 1 _ |a Papagiannopoulos, Christos
|0 0000-0003-4030-882X
|b 2
700 1 _ |a Aglago, Elom K
|0 0000-0002-0442-3284
|b 3
700 1 _ |a Berndt, Sonja I
|0 0000-0001-5230-0652
|b 4
700 1 _ |a Buchanan, Daniel D
|0 0000-0003-2225-6675
|b 5
700 1 _ |a Campbell, Peter T
|0 0000-0002-5549-2036
|b 6
700 1 _ |a Cao, Yin
|0 0000-0001-9835-7662
|b 7
700 1 _ |a Chan, Andrew T
|0 0000-0001-7284-6767
|b 8
700 1 _ |a Dimou, Niki
|0 0000-0003-1678-9328
|b 9
700 1 _ |a Drew, David A
|0 0000-0002-8813-0816
|b 10
700 1 _ |a French, Amy J
|0 0009-0002-3258-3653
|b 11
700 1 _ |a Georgeson, Peter
|0 0000-0002-5096-4735
|b 12
700 1 _ |a Giannakis, Marios
|0 0000-0001-9012-6982
|b 13
700 1 _ |a Gruber, Stephen B
|0 0000-0001-8656-7822
|b 14
700 1 _ |a Gunter, Marc J
|0 0000-0001-5472-6761
|b 15
700 1 _ |a Harrison, Tabitha A
|0 0000-0002-4173-7530
|b 16
700 1 _ |a Hoffmeister, Michael
|0 P:(DE-He78)6c5d058b7552d071a7fa4c5e943fff0f
|b 17
|u dkfz
700 1 _ |a Hsu, Li
|0 0000-0001-8168-4712
|b 18
700 1 _ |a Huang, Wen-Yi
|b 19
700 1 _ |a Hullar, Meredith Aj
|0 0000-0002-5322-9568
|b 20
700 1 _ |a Huyghe, Jeroen R
|0 0000-0001-6027-9806
|b 21
700 1 _ |a Lynch, Brigid M
|0 0000-0001-8060-547X
|b 22
700 1 _ |a Moreno, Victor
|0 0000-0002-2818-5487
|b 23
700 1 _ |a Newton, Christina C
|0 0000-0003-1471-5608
|b 24
700 1 _ |a Nowak, Jonathan A
|0 0000-0002-0943-7407
|b 25
700 1 _ |a Obón-Santacana, Mireia
|0 0000-0003-4646-3513
|b 26
700 1 _ |a Ogino, Shuji
|0 0000-0002-3909-2323
|b 27
700 1 _ |a Qu, Conghui
|0 0000-0003-1927-6245
|b 28
700 1 _ |a Schmit, Stephanie L
|0 0000-0001-5931-1194
|b 29
700 1 _ |a Steinfelder, Robert S
|0 0000-0003-4204-8013
|b 30
700 1 _ |a Sun, Wei
|0 0000-0002-6350-1107
|b 31
700 1 _ |a Thomas, Claire E
|0 0000-0001-9515-3277
|b 32
700 1 _ |a Toland, Amanda E
|0 0000-0002-0271-1792
|b 33
700 1 _ |a Trinh, Quang M
|0 0000-0002-3602-2290
|b 34
700 1 _ |a Ugai, Tomotaka
|0 0000-0003-0182-5269
|b 35
700 1 _ |a Um, Caroline Y
|0 0000-0001-5449-6230
|b 36
700 1 _ |a Van Guelpen, Bethany
|0 0000-0002-9692-101X
|b 37
700 1 _ |a Zaidi, Syed H
|0 0000-0001-9964-8285
|b 38
700 1 _ |a Murphy, Neil
|0 0000-0003-3347-8249
|b 39
700 1 _ |a Peters, Ulrike
|0 0000-0001-5666-9318
|b 40
700 1 _ |a Phipps, Amanda I
|0 0000-0002-1446-2201
|b 41
700 1 _ |a Tsilidis, Konstantinos K
|0 0000-0002-8452-8472
|b 42
773 _ _ |a 10.1158/1055-9965.EPI-24-1534
|0 PERI:(DE-600)2036781-8
|n 4
|p 568-577
|t Cancer epidemiology, biomarkers & prevention
|v 34
|y 2025
|x 1055-9965
909 C O |p VDB
|o oai:inrepo02.dkfz.de:298576
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 17
|6 P:(DE-He78)6c5d058b7552d071a7fa4c5e943fff0f
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2025
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2024-12-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2024-12-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2024-12-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2024-12-10
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-12-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-10
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CANCER EPIDEM BIOMAR : 2022
|d 2024-12-10
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2024-12-10
920 1 _ |0 I:(DE-He78)C070-20160331
|k C070
|l C070 Klinische Epidemiologie und Alternf.
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C070-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21